Test Code HIAAR 5-Hydroxyindoleacetic Acid, Random, Urine
Ordering Guidance
This test uses a random urine collection to assess 5-hydroxyindoleacetic acid concentrations. If a 24-hour urine collection is preferred, order HIAA / 5-Hydroxyindoleacetic Acid, 24 Hour, Urine.
Necessary Information
Patient's age and sex are required.
Specimen Required
Patient Preparation:
1. Some medications could interfere with test results. The ordering provider should decide if any medications should be stopped and when they should be restarted. If clinically feasible, discontinue the following medications at least 48 hours prior to specimen collection:
-Acetaminophen (Tylenol or generic versions)
-Tryptophan containing supplements
2. For 48 hours prior to the urine collection, the patient should:
Limit the following to one serving per day:
-Fruits
-Vegetables
-Nuts
-Caffeinated beverages or foods
Supplies: Urine Tubes, 10 mL (T068)
Container/Tube: Plastic, 10-mL urine tube
Specimen Volume: 5 mL
Collection Instructions:
1. Collect a random urine specimen.
2. Store and send refrigerate
Secondary ID
616090Useful For
Biochemical diagnosis and monitoring of intestinal carcinoid syndrome using random urine specimens
Method Name
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Reporting Name
5-HIAA, Random, USpecimen Type
UrineSpecimen Minimum Volume
2 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Urine | Refrigerated (preferred) | 56 days | |
Frozen | 365 days |
Reject Due To
All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.Clinical Information
5-Hydroxyindoleacetic acid (5-HIAA) is the major metabolite of serotonin and is excreted in the urine. Intestinal carcinoid tumors, along with neuroendocrine tumors, can produce excess amounts of 5-HIAA and serotonin, especially in individuals with carcinoid syndrome. Carcinoid syndrome is characterized by carcinoid tumors, flushing, heart disease, and hepatomegaly.
Measurement of 5-HIAA in a random urine specimen can diagnose carcinoid disease with a high specificity.
Reference Values
5-HIAA, mg/g creatinine 99th percentile cutoff |
|||
Age |
Female |
Male |
|
≤23 months |
≤17.53 |
≤16.42 |
|
24-35 months |
≤17.07 |
≤15.96 |
|
3 years |
≤16.70 |
≤15.60 |
|
4 years |
≤16.03 |
≤14.93 |
|
5 years |
≤15.26 |
≤14.17 |
|
6 years |
≤14.40 |
≤13.34 |
|
7 years |
≤13.47 |
≤12.43 |
|
8 years |
≤12.52 |
≤11.52 |
|
9 years |
≤11.58 |
≤10.63 |
|
10 years |
≤10.67 |
≤9.79 |
|
11 years |
≤9.81 |
≤9.00 |
|
12 years |
≤9.02 |
≤8.29 |
|
13 years |
≤8.32 |
≤7.65 |
|
14 years |
≤7.70 |
≤7.08 |
|
15 years |
≤7.16 |
≤6.59 |
|
16 years |
≤6.72 |
≤6.15 |
|
17 years |
≤6.36 |
≤5.78 |
|
18 years |
≤6.08 |
≤5.45 |
|
19 years |
≤5.88 |
≤5.17 |
|
20 years |
≤5.73 |
≤4.93 |
|
21 years |
≤5.64 |
≤4.73 |
|
22 years |
≤5.59 |
≤4.55 |
|
23 years |
≤5.57 |
≤4.40 |
|
24 years |
≤5.57 |
≤4.28 |
|
25 years |
≤5.58 |
≤4.19 |
|
26 years |
≤5.61 |
≤4.11 |
|
27 years |
≤5.64 |
≤4.06 |
|
28 years |
≤5.67 |
≤4.03 |
|
29 years |
≤5.70 |
≤4.02 |
|
30 years |
≤5.72 |
≤4.01 |
|
31 years |
≤5.75 |
≤4.02 |
|
32 years |
≤5.77 |
≤4.03 |
|
33 years |
≤5.78 |
≤4.05 |
|
34 years |
≤5.79 |
≤4.06 |
|
35 years |
≤5.80 |
≤4.08 |
|
36 years |
≤5.80 |
≤4.09 |
|
37 years |
≤5.80 |
≤4.11 |
|
38 years |
≤5.80 |
≤4.12 |
|
39 years |
≤5.81 |
≤4.14 |
|
40 years |
≤5.82 |
≤4.17 |
|
41 years |
≤5.85 |
≤4.22 |
|
42 years |
≤5.89 |
≤4.27 |
|
43 years |
≤5.95 |
≤4.35 |
|
44 years |
≤6.04 |
≤4.43 |
|
45 years |
≤6.14 |
≤4.53 |
|
46 years |
≤6.26 |
≤4.63 |
|
47 years |
≤6.40 |
≤4.75 |
|
48 years |
≤6.55 |
≤4.86 |
|
49 years |
≤6.71 |
≤4.99 |
|
50 years |
≤6.86 |
≤5.11 |
|
51 years |
≤7.01 |
≤5.24 |
|
52 years |
≤7.15 |
≤5.37 |
|
53 years |
≤7.29 |
≤5.51 |
|
54 years |
≤7.41 |
≤5.64 |
|
55 years |
≤7.52 |
≤5.78 |
|
56 years |
≤7.62 |
≤5.91 |
|
57 years |
≤7.71 |
≤6.05 |
|
58 years |
≤7.80 |
≤6.17 |
|
59 years |
≤7.88 |
≤6.29 |
|
60 years |
≤7.95 |
≤6.41 |
|
61 years |
≤8.02 |
≤6.51 |
|
62 years |
≤8.09 |
≤6.60 |
|
63 years |
≤8.15 |
≤6.69 |
|
64 years |
≤8.21 |
≤6.76 |
|
65 years |
≤8.28 |
≤6.82 |
|
66 years |
≤8.34 |
≤6.88 |
|
67 years |
≤8.40 |
≤6.93 |
|
68 years |
≤8.46 |
≤6.97 |
|
69 years |
≤8.52 |
≤7.00 |
|
70 years |
≤8.58 |
≤7.03 |
|
71 years |
≤8.65 |
≤7.06 |
|
72 years |
≤8.71 |
≤7.08 |
|
73 years |
≤8.77 |
≤7.10 |
|
74 years |
≤8.82 |
≤7.11 |
|
75 years |
≤8.86 |
≤7.11 |
|
76 years |
≤8.90 |
≤7.11 |
|
77 years |
≤8.92 |
≤7.10 |
|
78 years |
≤8.93 |
≤7.09 |
|
79 years |
≤8.93 |
≤7.07 |
|
80 years |
≤8.92 |
≤7.05 |
|
81 years |
≤8.90 |
≤7.02 |
|
82 years |
≤8.88 |
≤7.00 |
|
83 years |
≤8.86 |
≤6.98 |
|
84 years |
≤8.85 |
≤6.97 |
|
85 years |
≤8.84 |
≤6.95 |
|
86 years |
≤8.84 |
≤6.94 |
|
87 years |
≤8.84 |
≤6.94 |
|
88 years |
≤8.84 |
≤6.94 |
|
>or= 89 years |
≤8.85 |
≤6.93 |
|
Interpretation
If pharmacological and dietary artifacts have been ruled out, an elevated excretion of 5-hydroxyindoleacetic acid is a probable indicator of the presence of a serotonin-producing tumor.
CPT Code Information
83497
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
HIAAR | 5-HIAA, Random, U | 11145-0 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
616090 | 5-HIAA, Random, U | 11145-0 |